null

Phospho-MAPKAPK2-T334 Rabbit Polyclonal Antibody (CABP0396)

SKU:
CABP0396
Product Type:
Antibody
Applications:
WB
IHC
IF
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-MAPKAPK2-T334 Antibody CABP0396
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-MAPKAPK2-T334 Antibody CABP0396
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-MAPKAPK2-T334 Antibody CABP0396
€419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Phospho-MAPKAPK2-T334 Rabbit Polyclonal Antibody (CABP0396)

The Phospho-MAPKAPK2 (T334) Polyclonal Antibody (CABP0396) is a valuable tool for researchers studying MAPKAPK2, a protein kinase involved in cellular stress response pathways. This antibody, generated in rabbits, exhibits high specificity for detecting phosphorylation of MAPKAPK2 at threonine 334 in human samples and is suitable for Western blot applications. By targeting the phosphorylated form of MAPKAPK2, researchers can gain insight into the activation and regulation of this important signaling molecule in various cellular processes.MAPKAPK2 is a key regulator of cell growth, differentiation, and apoptosis in response to extracellular stimuli. Phosphorylation at threonine 334 is known to enhance the kinase activity of MAPKAPK2, influencing downstream signaling cascades that impact cell survival and proliferation.

Investigating the phosphorylation status of MAPKAPK2 provides valuable information on its role in stress responses and its potential as a therapeutic target for diseases associated with dysregulated cell signaling.Overall, the Phospho-MAPKAPK2 (T334) Polyclonal Antibody (CABP0396) offers researchers a reliable and specific tool for studying the phosphorylation status of MAPKAPK2 in various experimental settings, including cancer research, inflammation, and cellular stress response pathways. Its ability to detect phosphorylated MAPKAPK2 at threonine 334 provides a deeper understanding